Skip to Main Content

Paper Details

A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium study.
Neuro Oncol
9
2015
Akt, CNS malignancies, Enzastaurin, alanine, alanine transaminase, anemia, brain tumor, brainstem glioma, central nervous system malignancies, children, chromaturia, enzastaurin, ependymoma, fatigue, glioma, nausea, participants, patients, peripheral blood mononuclear cells, primary central nervous system tumors, protein kinase C, thrombocytopenia, tumor
Author NameAffiliation
Lindsay KilburnTexas Children's Cancer Center, Baylor College of Medicine, Operations and Biostatistics Center for Pediatric Brain Tumor Consortium, St. Jude Children's Research Hospital, R.G.) Ann and Robert H. Lurie Children's Hospital of Chicago, Center for Cancer and Blood Disorders, Northwestern University Feinberg School of Medicine, University of California San Francisco, Cincinnati Children's Hospital Medical Center,Cincinnati, University of Tennessee Health Science Center Memphis
Lindsay KilburnTexas Children's Cancer Center, Baylor College of Medicine, Operations and Biostatistics Center for Pediatric Brain Tumor Consortium, St. Jude Children's Research Hospital, R.G.) Ann and Robert H. Lurie Children's Hospital of Chicago, Center for Cancer and Blood Disorders, Northwestern University Feinberg School of Medicine, University of California San Francisco, Cincinnati Children's Hospital Medical Center,Cincinnati, University of Tennessee Health Science Center Memphis
Murali ChintagumpalaTexas Children's Cancer Center, Baylor College of Medicine, Operations and Biostatistics Center for Pediatric Brain Tumor Consortium, St. Jude Children's Research Hospital, R.G.) Ann and Robert H. Lurie Children's Hospital of Chicago, Center for Cancer and Blood Disorders, Northwestern University Feinberg School of Medicine, University of California San Francisco, Cincinnati Children's Hospital Medical Center,Cincinnati, University of Tennessee Health Science Center Memphis
Stewart GoldmanTexas Children's Cancer Center, Baylor College of Medicine, Operations and Biostatistics Center for Pediatric Brain Tumor Consortium, St. Jude Children's Research Hospital, R.G.) Ann and Robert H. Lurie Children's Hospital of Chicago, Center for Cancer and Blood Disorders, Northwestern University Feinberg School of Medicine, University of California San Francisco, Cincinnati Children's Hospital Medical Center,Cincinnati, University of Tennessee Health Science Center Memphis
Anuradha BanerjeeTexas Children's Cancer Center, Baylor College of Medicine, Operations and Biostatistics Center for Pediatric Brain Tumor Consortium, St. Jude Children's Research Hospital, R.G.) Ann and Robert H. Lurie Children's Hospital of Chicago, Center for Cancer and Blood Disorders, Northwestern University Feinberg School of Medicine, University of California San Francisco, Cincinnati Children's Hospital Medical Center,Cincinnati, University of Tennessee Health Science Center Memphis
Richard J GilbertsonTexas Children's Cancer Center, Baylor College of Medicine, Operations and Biostatistics Center for Pediatric Brain Tumor Consortium, St. Jude Children's Research Hospital, R.G.) Ann and Robert H. Lurie Children's Hospital of Chicago, Center for Cancer and Blood Disorders, Northwestern University Feinberg School of Medicine, University of California San Francisco, Cincinnati Children's Hospital Medical Center,Cincinnati, University of Tennessee Health Science Center Memphis
Maryam FouladiTexas Children's Cancer Center, Baylor College of Medicine, Operations and Biostatistics Center for Pediatric Brain Tumor Consortium, St. Jude Children's Research Hospital, R.G.) Ann and Robert H. Lurie Children's Hospital of Chicago, Center for Cancer and Blood Disorders, Northwestern University Feinberg School of Medicine, University of California San Francisco, Cincinnati Children's Hospital Medical Center,Cincinnati, University of Tennessee Health Science Center Memphis
  • 1 - 7

Datasets

Release 1.2